Antidepressants Flashcards
SSRIs
SNRIs
Atypical
Tricyclic
Escitalopram, fluoxetinem sertraline
Duloxetine, venlafaxine
Bupropion, mirtazapine
Amittriptyline, nortrip
Antidepressants vs mood stabilizers
Antidepressants for MD
Mood for BPD
Monoamine hypothesis
Depression causedb y monoamine deficiency
Diminished serotinin, adrenergic, dopaminerigc NT
SSRIs
SNRIs
Atypical
TCAs
effect on monoamines and onset
Serotonin
Serotonin and NE
Individual effects on serotonin, NE, or dopamine
Serotonin and NE
Onset make take several weeks so MOA could be more complicated
Most to least specific
SSRIs
SNRIs
Atypical
TCAs
Incidence and variety of adverse effects increase as you move to TCAs
Options for resistant depression
MOno
comb
Increase dose Switch to different class or same class
Careful use from two classes
Augmenting drug
Augmenting drugs
Apriprazole is most common
Lithium
Most are known to increase synthesis/release of monoamines
Use of SSRIs in depression
Usually drug of choice due to low incidence of side effects
Long delay for effects to occur (6-8 weeks)
SSRIs MOA
Main receptor is SERT, presynaptic transporter which removes 5HT from synaptic cleft
Additional targets could also enhance on pre and post membrane
BDNF effect
Increase serotonin means increase in BDNF means increase neuronal growth and synapse formation means reorganzation
In hippocampus
What is unique about escitalpram, sertraline and fluoxetine
Escitalopram is most specific
Sertraline is also weak inhibitor of dpoamine reuptake in addition to being an SSRI
FLu blocks NE reuptake and 5HT2C receptors in addition to SSRI
Discontinuation syndrome
GI symptoms, need to taper dose
Fluoxetine is best for this because long lived active mtabolite
SSRIs with CYP450 interactions
Fluoxetine and Sertraline
Serotonin syndrome
Basically all antidepressants except for bupropion and atypicals
Early - NM probs, cog probs, temp control
Late - Tonic-clonic convulsions
Any drugs that increase sertoonin
Adverse effects of SSRIs
Nausea, GI, cramping
Activating/insominia
Anorgasmia
Anti-platelet effect